Hyperpigmentation Treatment in Korea — Melasma, Sun Spots & PIH Solutions at Incheon Airport

Melanogenesis Pathways: Why Hyperpigmentation Occurs

Hyperpigmentation results from dysregulated melanogenesis — the biological process by which melanocytes synthesize and distribute melanin to surrounding keratinocytes. The rate-limiting step is catalyzed by tyrosinase, a copper-dependent enzyme that converts L-tyrosine to L-DOPA and subsequently to dopaquinone. From dopaquinone, the pathway branches toward eumelanin (brown-black pigment) or pheomelanin (yellow-red pigment) depending on the availability of cysteine and glutathione. In melasma, hormonal factors (estrogen, progesterone) and UV exposure upregulate tyrosinase expression and increase melanocyte dendricity, causing excessive melanin transfer to keratinocytes. In solar lentigines, chronic UV exposure induces focal melanocyte proliferation and persistent tyrosinase activation. In PIH, inflammatory mediators (prostaglandins, leukotrienes, cytokines) stimulate melanogenesis as a protective response to skin injury. Passeron and Picardo (2018) established that these distinct pathogenic mechanisms necessitate different therapeutic approaches — a principle central to Korean pigmentation treatment philosophy.

Passeron T, Picardo M. Melasma, a photoaging disorder. Pigment Cell Melanoma Res. 2018;31(4):461-465. doi:10.1111/pcmr.12684

Low-Fluence Laser Toning: The Korean Innovation

Low-fluence Q-switched and picosecond laser toning was pioneered in Korea specifically to address the challenge of treating pigmentation in Fitzpatrick skin types III-V without triggering rebound hyperpigmentation. The principle is straightforward: rather than using high-fluence energy to destroy melanin deposits aggressively (which triggers massive melanocyte inflammation and paradoxical darkening), low-fluence toning delivers sub-threshold energy across the entire treatment area, gradually reducing melanin concentration over multiple sessions. Cho et al. (2009) published the seminal study demonstrating that low-fluence 1064nm Nd:YAG laser toning produced significant melanin index reduction in melasma patients over 5-10 weekly sessions, with minimal risk of post-inflammatory hyperpigmentation. The subsequent development of picosecond laser platforms (including PicoSure) further improved upon this approach — the ultra-short pulse duration (375-750 picoseconds) creates photomechanical melanin disruption rather than photothermal injury, reducing the inflammatory stimulus that drives melanocyte rebound while improving melanin clearance efficiency.

Cho SB, Kim JS, Kim MJ. Melasma treatment in Korean women using a 1064-nm Q-switched Nd:YAG laser with low pulse energy. Clin Exp Dermatol. 2009;34(8):e847-e850. doi:10.1111/j.1365-2230.2009.03460.x

Combination Therapy: Synergistic Multi-Modality Approach

The evidence increasingly supports combination therapy over monotherapy for hyperpigmentation management. Sarkar et al. (2012) demonstrated in a randomized controlled trial that combination treatment (laser toning + topical depigmenting agents) produced significantly greater melanin index reduction than either modality alone. The scientific rationale is that each treatment addresses a different component of the hyperpigmentation pathway: laser toning physically destroys existing melanin deposits, chemical peels accelerate the turnover of melanin-laden keratinocytes, topical tyrosinase inhibitors prevent new melanin synthesis, and skin boosters (Rejuran, Juvelook) improve the dermal environment to reduce melanocyte stimulation from inflammatory mediators. The Korean One-Day Customized Pigmentation Care Package embodies this philosophy by combining Potenza RF (dermal remodeling), Rejuran Healer (polynucleotide-based tissue regeneration), personalized laser toning, LDM (anti-inflammatory micro-massage), and a modeling mask — each component targeting a distinct layer and mechanism of the hyperpigmentation cascade.

Sarkar R, Arora P, Garg KV. Cosmeceuticals for hyperpigmentation: what is available? J Cutan Aesthet Surg. 2013;6(1):4-11. doi:10.4103/0974-2077.110089

Potenza RF Microneedling for Deep Pigmentation

For hyperpigmentation with a significant dermal component — common in chronic melasma and certain types of PIH — radiofrequency (RF) microneedling adds a therapeutic dimension that laser alone cannot reach. The Potenza platform delivers bipolar RF energy through insulated microneedles directly into the dermis, creating controlled thermal zones that stimulate collagen remodeling and drug delivery enhancement without epidermal damage. When combined with depigmenting agents like exosomes or skin boosters, the microchannels created by Potenza needles facilitate transdermal delivery of active compounds to the dermal-epidermal junction where melanocyte activity is concentrated. This approach is particularly valuable for melasma with a dermal melanin component, which is notoriously resistant to surface-level treatments alone. At RE:BERRY, Potenza is incorporated into the One-Day Customized Pigmentation Care Package with customized skin boosters (Exosome or Juvelook) to deliver depigmenting and regenerative agents directly to the targeted dermal depth.

Shin MK, Lee JH, Lee SJ, Kim NI. Platelet-rich plasma combined with fractional laser therapy for skin rejuvenation. Dermatol Surg. 2012;38(4):623-630. doi:10.1111/j.1524-4725.2011.02280.x